These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance. Hussein MS, Abushady MM, Refaat S, Ibrahim R. Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596 [Abstract] [Full Text] [Related]
6. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L. J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154 [Abstract] [Full Text] [Related]
8. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. Calanna S, Piro S, Di Pino A, Maria Zagami R, Urbano F, Purrello F, Maria Rabuazzo A. Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781 [Abstract] [Full Text] [Related]
11. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women. Emara MK, Saadah A, Hassan M, Moussa M, Hourani H. Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944 [Abstract] [Full Text] [Related]
12. Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects. Verrillo A, de Teresa A, Martino C, di Chiara G, Verrillo L. Regul Pept; 1988 Jun; 21(3-4):185-95. PubMed ID: 2901133 [Abstract] [Full Text] [Related]
14. [Changes in plasma glucagon concentration in patients with diabetes mellitus and its clinical significance]. Tang S. Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):222-4, 255. PubMed ID: 1327451 [Abstract] [Full Text] [Related]